Which glucose monitor works best for insulin users?
NCT ID NCT07308925
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a real-time continuous glucose monitor (CGM) helps people with type 2 diabetes on insulin keep their blood sugar in a healthy range better than an intermittent CGM. About 108 adults with poorly controlled diabetes will use one of the two monitors for a period. The goal is to see which device leads to more time with blood sugar between 70 and 180 mg/dL.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Universitario San Ignacio
Bogotá, 111121, Colombia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill could offer new hope for weight loss in east asian adults
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Hormone clue may unmask kidney danger in diabetes
- Can a single pill tackle both fatty liver and diabetes?
- Does when you eat carbs and protein reshape blood sugar control?